drugset / Press release

IVIEW Therapeutics will present its novel sustained-release povidone iodine ophthalmic formulation for the treatment of acute conjunctivitis in TechConnect World Innovation Summit & Expo and US National Innovation Summit and National SBIR/STTR Conference

2018-03-26 · IVIEW Therapeutics Inc. · original iviewtherapeutics.com ↗

March 26, 2018 iVIEW Therapeutics Inc. is pleased to announce Dr. Bo Liang, President will present in 2017’s TechConnect World Innovation Summit & Expo and US National Innovation Summit and National SBIR/STTR Conference, May 15-17, 2017, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD. In addition of accepted oral paper presentation scheduled at 11:55am on May 17, iVIEW was accepted to showcase the technology during the conference. Submission Number: 2145 Technology Title: Development of a Novel in-situ Gel Povidone Iodine Ophthalmic Drop for the Treatment of Viral Conjunctivitis http://techconnectworld.com/World2017 Congratulations! Submission 2145, Development of a Novel in-situ Gel Povidone Iodine Ophthalmic Drop for the Treatment of Viral Conjunctivitis, has been ACCEPTED for a SHOWCASE BOOTH at this year’s TechConnect World Innovation Summit & Expo, co-located with the National Innovation Summit and National SBIR/STTR Conference, May 15-17, 2017, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD. Abstract submission number: 896 Title: DEVELOPMENT OF SUSTAINED RELEASE POVIDONE IODINE OPHTHALMIC DROP THROUGH NOVEL IN-SITU GEL FORMULATION Authors: G. Wei, X. Gao, X. Li, Y. Lu, J.J. Baldwin, B. Liang This title may be found in the general online program, or you may find it in the Symposium assignment here: http://www.techconnectworld.com/World2017/sym/Materials_Drug_Gene_Delivery.html Congratulations! We are pleased to inform you that the submission 896 has been accepted for ORAL Presentation at the 2017 TechConnect World Innovation Conference and Expo, to be held May 15-17, 2017, at the Gaylord National Resort and Convention Center, National Harbor, Maryland, just outside of Washington, D.C., U.S.A.

The release as fetched from its publisher. iviewtherapeutics.com ↗